Ritonavir Completed Phase 2 Trials for Chronic hepatitis C genotype 1b Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03485846Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-NaŃ—ve Patients With Chronic Hepatitis C Genotype 1b